scispace - formally typeset
J

Johanna van der Ven-Jongekrijg

Researcher at Radboud University Nijmegen Medical Centre

Publications -  9
Citations -  373

Johanna van der Ven-Jongekrijg is an academic researcher from Radboud University Nijmegen Medical Centre. The author has contributed to research in topics: Tumor necrosis factor alpha & Septic shock. The author has an hindex of 8, co-authored 9 publications receiving 351 citations. Previous affiliations of Johanna van der Ven-Jongekrijg include Radboud University Nijmegen.

Papers
More filters
Journal ArticleDOI

The Pattern of Interleukin-1β (IL-1β) and Its Modulating Agents IL-1 Receptor Antagonist and IL-1 Soluble Receptor Type II in Acute Meningococcal Infections

TL;DR: During the early stage of meningococcal infections IL-1Ra modulatesIL-1 activity, whereas during recovery IL-2sRII may be more important, which suggests different modulation of IL- 1beta activity in the subarachnoid space and the plasma compartment.
Journal ArticleDOI

Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome

TL;DR: The data demonstrate that IL-1β plays a pivotal role in this disease, and monthly 150 mg canakinumab injection was an effective and well-tolerated treatment for Schnitzler's syndrome.
Journal ArticleDOI

Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release.

TL;DR: It is demonstrated that Chlamydia pneumoniae is an important stimulus for IFN-gamma synthesis, and this production depends on release of endogenous IL-18, IL-12, and IL-1, but not of TNF, which may contribute to its proatherogenic effects.
Journal ArticleDOI

Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.

TL;DR: The expression of DLD mRNA in several human tissues, particularly in the skin, consistent with its putative role as a defensin against invading microorganisms is shown, the first indication of an endogenous human peptide with specific antifungal activity.
Journal ArticleDOI

Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever

TL;DR: Although ciprofloxacin was more effective in the elimination of Salmonellaenterica serovars Typhi and Paratyphi A from bone marrow than chloramphenicol, there was still an impressive persistence of Salbornella in the bone marrow culture.